About Celyad Oncology SA

Company Description

Celyad Oncology is a biotechnology company focused on the research and discovery of chimeric antigen receptor T cell (CAR T) therapies for cancer. The Company is focusing on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property and support the development of next-generation CAR T candidates in solid tumors and hematological malignancies.

Year founded

2004

Served area

Worldwide

Headquarters

Axis Business Park Rue Edouard Belin 2, 1435 Mont-Saint-Guibert, Brabant wallon – Belgium

Shareholder information

Shares outstanding

22,593,956

IPO

July 5, 2013

Stock exchange(s)

Euronext Brussels

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.